The aim of this study is to explore the effect of Transarterial Chemoembolization (TACE) on the prognosis of patients with microvascular invasion presence(MVI) and overexpression of Aspartate-β-hydroxylase(ASPH).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
180
Patients will treated by TACE in 4 or 8 weeks after operation.
Eastern hepatobilliary surgery hospital
Shanghai, Shanghai Municipality, China
Overall Survival
Time frame: 3 years
Time to recurrence
Time frame: 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.